前苏联专利SU1604159A3 Method of producing macrolidic compounds

专利PDF首页>>前苏联专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
Compounds with acaricidal, insecticidal and anthelmintic activities have the formula: <CHEM> wherein: -X-Y- is -CH2-CH2-, -CH2-CHOH-, -CH=CH-, or -CH2-C(=O)-; R<1> is a methyl group, an ethyl group, an isopropyl group, a sec-butyl group or a group of formula -C(CH3)=CHR<5> in which R<5> is a methyl group, an ethyl group or an isopropyl group; R<2> represents a group of formula -(CH2)n-C(R<6>)=C(R<7>)(R<8>) in which n is 0, 1 or 2, R<6> and R<7> each is a hydrogen atom or a methyl group and R<8> is a hydrogen atom, a C1-4 alkyl group, a phenyl group or a phenyl group substituted with at least one substituent selected from halogen, methyl and/or nitro substituents; R<3> is a hydrogen atom, a methyl group, a hydroxy-protecting group, an ester-forming carboxylic acid residue, or an ester-forming carbonic acid residue; and R<4> is a hydrogen atom or an alpha -L-oleandrosyl- alpha -L-oleandrosyloxy group, with the proviso that R<4> represents a hydrogen atom when the group R<1> is a methyl group, an ethyl group, or a group of formula -C(CH3)=CHR<5> in which R<5> is a methyl group, an ethyl group or an isopropyl group.
公开号:SU1604159A3
申请号:SU4613316
申请日:1989-01-23
公开日:1990-10-30
发明作者:Оказаки Такао
申请人:Санкио Компани Лимитед (Фирма)；
IPC主号:

专利说明:

04
This invention relates to a process for the preparation of new macrolide compounds that possess acaricidal, insecticidal and antihelminthic
activities, and can be used in agriculture.
The purpose of the invention is to obtain new macrolide compounds possessing I
more valuable pesticide properties.
There are several classes of known compounds with a structure based on a sixteen membered macrolide cycle. Examples of two such classes of known substances are milbemycins and avermectins, but there are also various other classes that are identified using macrolide substances, usually taken from the names or code numbers of microorganisms that produce members of each class found in nature, and then these names are distributed encompassing chemical derivatives of the same class. As a result, there is no standardized systematic nomenclature for general use of such substances.
The description will refer to names that are based on a hypothetical generic substance represented by the formula
SNZ „about 23
sn
(BUT)
Avermectins are defined as follows.
In Table 1, the substituent is at position - 25, R ,, the substituent is at position - 23, and R is the substituent at position 5, ds is the double bond between the positions - 22 and 23, and the PS is a simple (single) bond between positions - 22 and - 23.
Specific.: Examples of the compounds obtained include those listed in Table 2.
CD
u f5; 20
25
thirty
35
40
45
0
five
In table 2 substances have the following names:
26- (3-methyl-2-butenoyloxy) m-1 bemycin AZ;
3) 26- (3-metsh1-2-butenoyloxy) msh1-bemycin A);
4) 26- (3-methyl-2-pentenoyloxy) m-1-bemycin 4;
5) 26- (2-butenoyloxy) milbemycin
6) 26- (2-metsh1-2-butenoyloxy) m-1 bemycin A (j;
7) 26- (2-hexenoyloxy) milbemycin
8) 26- (4-methyl-2-pentenosiloxy) milbemycin
. 9) 26- (3-hexenoyloxy) milbemi-.cin
10) 26- (4-pentenoyloxy) milbemycin A4;
1.1) 26-cinnamoyloxins A. bemycin A.)
12) 26-p-chlorocinnamoylox1 1-ilbemycin A4;
14) 5-o-propion-1-2- (3-methyl-2-buteno-1oxy) m-1 bemicin
15) 5-o-ethoxycarbonyl-2- (3-methyl-2-butenoshloxy) pb1 bemicin
16) 26- (3-methyl-2-butenoyloxy) milbemycin D;
17) 26- (3-methyl-2-butenoyloxy) ivermectin B;
18) 26- (3-methyl-2-butene 1). avermectin V d;
19) 23-deoxy-26- (3-metsh-1-2-butenoyloxy) S-541A;
20) 26- (3-m8til-2-butenoyloxy) S-541A.
Example 1. 26- (2-Butenosh1oxy). milbemycin A4 (compound 5).
24 µl of pyridine and Z9. Mkl of 2-butenoyl chloride are added to a solution of 150 mg of 26-hydroxy-5-0-tert-butyldimethylsilylmylbemycin A4 in 2 ml of methylene chloride cooled to, then the mixture is stirred at room temperature in for 3 hours. The reaction mixture is poured into ice water and extracted with ethyl acetate. The extract is dried over anhydrous sodium sulfate and concentrated by boiling. The residue is dissolved in 4 ml of acetonitrile, which is then cooled to 0 ° C. 0.5 ml of 68% hydrogen fluoride in pyridine is added to the solution and the mixture is stirred at room temperature for 1.5 hours. The reaction mixture is then poured into ice-water and extracted with ethyl acetate. Extract
516
washed with saturated sodium bicarbonate aqueous solution, dried over anhydrous sodium sulphate and concentrated by mixture. The residue was purified by preparative thin layer chromatography to obtain 66.5 mg of the target compound (yield 48%).
Mass spectrum (electron bombardment method, M (Z): 626 (M); 540; 522; 414; 264j 245; 191; 167; 151.
Nuclear Magnetic Resonance Spectrum (270 MHz, CDC1 ,, h / mpn): 1.99 (MN, doublet of doublets, J 6.9, 1.6 Hz, CH-CH3 CH-COO-); 3.08 (1H, doublet of triplets, J 2.4, 9.3 Hz,); , 84 (W, doublet, J 13.3 Hz,); 5.87 (1H, quartet of doublets, J 1.6, 15.3 Hz, CH-CH, CH-COO-); 7.08 (1H, quartet of doublets, J 6.9, 15, 3 Hz, CH-CH5 CH-COO-).
EXAMPLE 2: 26- (3-Methyl-2-buteno-loxy) milbemycin D (compound 16).
0.15 ml of 3-methyl-2-butenoyl chloride 1 is added to a solution of 177.3 mg of 26-.,
hydroxy-5-O-tert-butyldimethylsilyl-milbemycin and O, 1 ml of pyridine in 15 ml of methylene chloride cooled to about C. The mixture is then stirred for 2 hours. The reaction mixture is poured into a saturated aqueous solution of sodium bicarbonate and extracted with methylene chloride. The extract is dried over anhydrous magnesium sulphate and concentrated by evaporation. The residue is dissolved in 10 ml of acetonitrile and then cooled to 0 ° C. 1 ml of 68% hydrogen fluoride in pyridine is added to the solution and the mixture is stirred for 2 hours. The reaction mixture is then poured into a saturated aqueous solution of sodium bicarbonate and extracted with ethyl acetate. The extract is dried over anhydrous magnesium sulphate and concentrated by evaporation. The residue was purified by silica gel column chromatography to give 144.7 mg of the target compound (yield 86%).
Mass spectrum (electron bombardment method, M (Z): 654 (M); 618; 554; 428; 410; 356.
NMR spectrum (270 MHz, CDClj, ppm); 3.07 (1H, broad doublet, J 7.7 Hz,); 4.48 (1H, broad doublet, J 4.0 Hz, CjH); 4.68 (W, doublet, J 14.7 Hz, CgbN); A, 79 (W, doublet, J 14.7 Hz, C-GBN).
6
SN h-CH
five
0
five
0
35
Following one tjs according to the methods of examples 4 and 5, a half-way. the following compounds.
PRI me R 3. 26- (2-Methyl-2-butenoyloxy) milbemycin A (compound
6) Facc-spectrum (electronic
bombardment, M (Z): 640 (-) j 604; 540; 522, 414.
NQR spectrum (270 Hz, AHSC, ppm): 1.80 (ZN, doublet, J 7.2 Hz, C (SKZ) -SOO); 1.85 (OG, singlet, CHj-CH C (CK,) COO-); 3.08 (1b, doublet of triplets, J 2.4; 9.3 Hz) t 4.73 (IH, doublet, J 13.7 Hz, C.N).
EXAMPLE 4. 26- (2-Hexenoyloxy) milbe1 shtsin A4 (compound 7).
Mass spectrum (electron bombardment method, N (Z): 654 (M); 618; 522; 504; 414; 396.
NMR spectrum (270 MHz, CDC1j, ppm): 0.93 (3N, triplet, J 7.3.Hz, CH - -CH, CH2, CH CH-COO-); 4.02 1H, doublet, J 13.3 Hz,); 4.86 (1H, doublet, J 13.3 Hz,); 7.01 (H, triplet of doublets, j 6.9, 15.7 Hz, С Н-г-СН CH-COG-).
PRI me R 5. 26- (4-Methyl-2-penthenoyloxy) milbemycin A (compound 8).
Mass spectrum (electronic
bombardment, M (Z): 654 (M); 618; 522; 414; 396.
Nuclear Magnetic Resonance Spectrum (270 MHz, CDC1, ppm): 1.07 (6H, doublet, J 6.9 Hz, (СН,). СН-СН СН-СОО-) ;; 3.08 (W, doublet
J 2.4 Hz, 9.3 Hz,);
40
triplets
4.72 (1H, doublet, J
4.86 (W, doublet, J
13.3 Hz, 13.3 Hz,
CgNH); SgbN);
45
50
55
6.99 (1H, doublet of doublets, J 6.5, 15.7 Hz) (CH3) 2.CH-CH CH-COO-).
PRI me R 6. 26- (3-Hexenoxy) milbemycin A (compound 9).
Mass spectrum (electron bombardment method, M. (Z): 654 (M); 414; 279; 195 | 167.
NMR spectrum (270 MHz, CDClj, ppm); 3.07 (2H, doublet, J 6.4, CH-C2 H5 CH-CH-COO-); 4.68 (1H, doublet, J = 1279 Hz, CggH); 4.79 (1H, doublet, J 12.9 Hz,).
PRI me R 7. 26- (4-Pentenoylox) milbemycin AI). (Compound 10).
Mass spectrum (electron bombardment method, M (Z): 640 (); 604; 522; 264; 195; 167.
NMR spectrum (270 MHz, SOS1e, ppm); 3.07 (W, doublet of triplets, J 2.4,
9.3 Hz,); .69 (IH, doublet, J 13.7 Hz,); 4.79 (IH, doublet,
. J 3.7 Hz, C2bN); 4.99 - 5.10 (2H, multiplet, CH2 CH-CH CH2.-COO-)
Example 26-Cinnamoyloxy-milbemycin AI. (Compound 1: 1).
Mass spectrum (electron bombardment method, M (Z): 688 (M); 652; 522; 276; 195; 167.
NMR spectrum (270 MHz, CBC1H, ppm) 3.07 (1I, doublet of triplets, .T 2.4, 9.7 Hz, CgfH); 4.81 (1H, doublet, J 13.3 Hz, CgbN); 4.89 (W, doublet, J 13.3 Hz, C-GBN); 6.47 (W, doublet, J 16.1 Hz, Ph - CH CH - —COO-); 7.72 (W, doublet, J 16.1 Hz Ph - QH).
PRI me R 9. 26-p-chlorocinnamoyloxymyl bemycin A (compound 12).
Mass spectrum (electron bombardment method, M (Z): 722 (M +); 704; 540; 522; 504.
Nuclear Magnetic Resonance Spectrum (270 MHz, SBS1z, m / m) 3.07 (1H, doublet triplets, J 2.4, 8.9 Hz, CjjH); 4.81 (1H, doublet, J 13.3 Hz, CifeH); 4.93 (W, doublet, J 13.3 Hz,) 6.44 (1H, doublet, J 16.1 Hz, n-Ch-Ph-CH CH- —COO-); 7.67 (W, doublet, J 16.1 Hz n-Cl-Ph-CH CH-COO-).
Example 10, 5-o-propionst-2- (3-methyl-2-buteno-1oxy) milbemycin A, (compound 14).
Mass spectrum (electron bombardment method, M (Z): 696 (M); 604; 504; 414; 396; 356; 264; 195; 167; 151.
Nuclear Magnetic Resonance Spectrum (270 MHz, CDClg, ppm): 1.15 (3N, triplet, J = 7.6 Hz, CJ CHiCO-); 2.40 (2H, quartet, J 7.6 Hz,); 3.07 (1H, Shea
roy triplet, J 8.0 Hz,); -, 15 (1H, doublet, J 6.0 Gp, Cg H); 4.50-4.76 (4H, multiplet, .CjvH); 5.65-5.95 (5H, multiplet, C, H, CjH, C, H, C, (, HfCH) i (C CH-COOr).
Example II 5-o-Ethoxycarbogyl-2- (3-methyl-2-butenoyloxy) milbemycin A (compound 15).
Mass spectrum (electron bombardment method, M (Z): 712 (M); 414; 396; 264; 195; 167; 151.
Nuclear Magnetic Resonance Spectrum (270 MHz, CDCl, ppm): 1.31 (3N, triplet, J 7.1 Hz, CH3CH, AORO-); 3.07 (1H, triplicate doublet, J 2.4, 8.9 Hz); , (1H, doublet, J 6.1 Hz, CgK); .4.19 (2H. Quartet, J 7.1 Hz,

0
five
0
with
0
five
SN ,, SNGOSOO-); 4.57-4.76 (4H, multiplet, C2bH,); 5.54 (1H, doublet of doublets, J 1.6, 6.1 Hz, Cj-H).
Example 12. 26- (3-Methyl-2-butenoyloxy) Ivermectin B. (compound .. 17).
Mass spectrum (FAB method; triethanolamine M (Z) added: 1014; 992; 978; 962; 934; 878; 830; 299; 194.
NMR spectrum (270 kHz, CDCl (h / ml): 3.07-3.29 (OTH, multiplet,,, CijH); 3.35 (1H, singlet,); 3.48 (6H, singlet, two OCH3); 3.97 (W, doublet, J 6.1 Hz, CgH); 4.49 (1H, broad singlet, Cj-H); 4.69 (2H, broad singlet); 4.97 (1H , wide doublet, J 7.3 Hz,
).
Example 13. 26- (3-Methyl-2-butenoyloxy) S-541A (compound 20).
Mass spectrum (method of electron bombardment, M (Z): 710 (M); 592; 523; 468; 448; 423; 376.
Nuclear Magnetic Resonance Spectrum (270 MHz, CBC1H (ppm): 3.75 (W, doublet, J 10.9 Hz, CjyH); 4.67 (W, doublet, J 13.3 Hz, CrH); 4, 82 (W, doublet, J 13.3 Hz,); 5.20 (W, doublet, J 8.9 Hz,).
Example 14. Milbemycin A (compound 3).
Mass spectrum (electron bombardment method, m / Z): 640; 540; 522; 276; 263; 195; 167.
Nuclear Magnetic Resonance Spectrum (COP1e, 270 MHz): 3.09 (1H, doublet of triplets, J 2.4, 9.3 Hz, CjjH); 4.00 (W, doublet,
J 6.6 Hz, --- -.
multiplet.
0 wide singlet,).
); 4.64-4.88 (4H, CgbN, 5.81 (1H,
The substances of formula I possess pre-. a rising acaricidal activity against adults and herpes of two-sided spider kpestyka (Tetrany-5 chus), citrus red; Tick Maker (Rapopus), Bvopace; pro red mite and rust mites, which are parasites for fruit trees, vegetables, and flowering plants and against Ixodiolae, Dermanys-side, Sarcoptidae and other parasites that parasitize animals. In addition, these substances impose activity against Oestrus, Luccilia, Hypoderma, Gautrop hilus, fleas and lice, among which others are parasites against BOTiaix animals and birds, domestic insects such as cockroaches, domestic flies and animals.
other insects, and various insects harmful to agricultural and horticultural crops, such as tl, cabbage moth, and Lepidoptera caterpillar. In addition, the substances of this invention possess activity against Meloidohuhe, Bursaphelenchus, Rhizogluphus and other species
In addition, the compounds of formula I possess excellent parasiticidal activity against endoparasites of animals and humans. Especially these substances are effective not only against nematodes, parasitic, domestic animals and domestic birds and animals such as pigs, sheep, goats, cattle, horses, dogs, cats and feather game, but also against parasites, found in digestive tracts, blood and other tissues and in humans and parasites belonging to the genus Filariidae or Setariidae.
When the substances of this invention are intended for use in agricultural or horticultural purposes, they may be formulated as preparations that have traditionally been used for agricultural chemicals, such as dusts, moisturizing powders, emulsifiable concentrates, aqueous or oily suspensions. aerosols, by mixing them with carriers or other auxiliary agents if necessary. Carriers can be natural or synthetic and inorganic or organic substances,. which are incorporated into agricultural formulations in order to help achieve the goal of the active ingredient and make it more convenient to store, transport and handle the active ingredient.
In order to improve the properties of the formulation and enhance the biological effect, the compositions of this invention can be used in combination with high molecular weight compounds or other excipients such as casein, gelatin albumin, glue, sodium alginate, carboxymethylcellulose, methylcellulose, hydroxyethylcellulose, and polyvinyl alcohol.
After the recipe is compiled in various ways, the composition
0
five
0
five
0
5910
This invention can be effectively applied to crops and domestic animals on which harmful insects or mites parasitize, on rice fields, orchards and upland fields, by treating the stems and leaves of cultivated plants, soil or domestic animals at concentrations of 0, 5-100 ppm active ingredient.
When the compounds of formula I are intended for use in animals or humans as an anti-helminth agent, these substances can be administered orally as a beverage. Typically, the beverage is a solution, suspension or dispersion with a suitable non-toxic solvent or water, together with a suspending agent such as bentonite and / wetting agent, or any other carrier. The drink also contains an antifoaming agent. Typically, the composition of the beverage includes approximately 0.01 to 0.5 wt.%, Preferably 0.01 to 0.1 wt.%, Of the active ingredient.
When the compounds of the formula I are intended to be supplied to animals as food, these substances can be used by homogeneous dispersion in food, by feeding or in the form of tablets. In order to get the desired counter 35
40
45
50
55
the helminth effect, the active components must be present in the general form of the final concentration in food of 0.0001-0.02%.
The compounds of formula I may also be administered parenterally to animals by injection into the anterior section of the stomach, muscle, trachea, or by subcutaneous injection as a solution or dispersion in a liquid carrier. For parenteral administration, the active substances may preferably be mixed with a suitable vegetable oil, such as peanut oil or hlp oil. Typically, this type of formulation contains 0.05-50% by weight of the active ingredient.
The compounds of the formula I can also be administered locally by mixing them with a suitable carrier such as dimethyl sulfoxide or a hydrocarbon solvent. This type of formulation can be applied directly to the surface of the animal’s body using a jet or
Id
by direct ing
1,
The most appropriate dosage to obtain the best result depends on the type of animal to be treated and the type and degree of infection by the parasite. The dosage is 0.01-100 mg, preferably 0.5-50.0 mg per kg body weight of the animal. The dosage can be set once or in several divided doses for a relatively short period, for example, 1-5 days.
Example 15, Activity Tests: Adult Ticks.
Samples of solutions were prepared, each of which contained 0.3, 1, or 3 h, ppm of individual compounds of the invention or one of three control compounds (milbemycin C, a mixture of milbemycin C and milbemycin Cj, 26-acetoximesh1 af or 2b - acetoxy avermectin B and 0.01% spreder),
Tetranychus urticae duplex spider mites sensitive to organophosphorous insecticides were inoculated on the primary leaf of the cowpea plant (Vigna sinensis Savi). A day after the inoculation, using a rotary sprinkler, distributed 7 ml of a sample of the solution indicated above, the sprinkler from Mizuho Seisokusho Co., to obtain a distributed amount of 3.5 mg / cm of leaf. After spraying, the leaf was left at room temperature at 25 ° C. After three days, the state of the adult insects was evaluated using a binocular microscope and the mortality (%) was calculated.
The results are shown in Table 3.
When Mve p 16, Activity Testing: Tick Egg
Samples of solutions were prepared, each of which contained 1 h or 3 h, ppm of individual compounds of the invention, or one of the three control compounds (milbemicin C, a mixture of milbemycin C and milbemycin Cg, 26-acetoxymylbemicine A4 or 26-acetoxy avermectin Bw and .0.01% spreader),
The females of two-spotted spider-like mites were allowed to lay eggs on the primary leaf of the cowpea plant. Adult ticks removed from
by emitting test leaves with 50 eggs laid upon them,
Samples of the solutions were applied to the test leaves according to the method described in Example 15. After 2 weeks in a room at a temperature, the number of eggs that did not ripen (the number of not hatched individuals) was counted and evaluated as a percentage.
The results are presented in Table 4.
Thus, the milbemycins of the invention showed high acaricidal activity against adult ticks at levels as low as 0.3 ppm, and also showed beneficial ovicidal activity.

权利要求:
Claims (1)
[1]
Invention Formula
The method of producing macromide compounds of formula
ABOUT
SNGOSKg
0
0
five
or -CHg -CHOH where
5 where and
where is X-Y
Group;
ethyl, isopropyl, fluoro-butyl or the group -C (CH3) CHRj,
Rp is isopropyl;
formula group
- (CH) - C (Rg) C (R7) (R8), is an integer equal to O, 1
or 2;
Rg is each hydrogen atom or R, methyl;
a hydrogen atom, (. -alkshl, phenyl, unsubstituted or substituted by a halogen atom; a hydrogen atom, CORo-rpjmna or COOR (j-rpynna, C, -C4-alkyl;
a hydrogen atom or oi-L-olendrozil, O-L-oleoavdrosyl-hydroxy group,
with the proviso that Kf is a hydrogen atom when the R group is ethyl or the fori group
RO R, where R.
R
13J50A:
mules -C (CH.) - CHR, where Ry is isopropyl, characterized in that the compound of the formula "Y t"
t LT
TI Go "1-
In Table 2, c6-alLa-L-oleandprodin-oi-L-ol8andproject; DMV - 1,3-dimethyl -1-b uthenyl
591
where -X-Y-, R ,, Kz and R4 have the indicated meanings, are esterified. acid chloride formula
R-COC1,
Table 2
1b
1604159
Table3
(al
A4
3
10 5
6
7
eight
ten
15 1 15 16
27-Acetoxymyl- 20 bemycin A 4. 26-Acetoxy-avermectin,
16 TableA
il -,
95 94 62 77 55 53 82 63 67 2.7
31 4.2
57
45
33
50
23 23 41 20 21 2.1
12 2.4

类似技术:

公开号 | 公开日 | 专利标题

RU2024527C1|1994-12-15|Method of macrolide compounds synthesis

SU1604159A3|1990-10-30|Method of producing macrolidic compounds

KR100224292B1|1999-10-15|Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b

US4547520A|1985-10-15|5-Oxime derivatives of milbemycins and veterinary and agricultural use thereof

Drew1987|Behavioural strategies of fruit flies of the genus Dacus | significant in mating and host-plant relationships

SK278513B6|1997-08-06|Antihelmintic avermectine derivatives and an agent containing these derivatives, for parasitic infections treatment

SU1537140A3|1990-01-15|Method of producing derivatives of 13-haloidmylbemicine or their salts, or their esters

DK159711B|1990-11-26|Insecticidal preparation comprising synthetic pyrethroids, and use of the preparation

JPH07108908B2|1995-11-22|1,2,3,6-Tetrahydro-5-nitro-pyrimidine derivative

KR900008698B1|1990-11-27|Process for the preparation of milbemycin d derivatives

US4721727A|1988-01-26|Control of pests with annonaceous acetogenins

KR940006632B1|1994-07-23|Process for preparing macrolide compounds

SU586820A3|1977-12-30|Method of fighting insects and ticks and pesticide composition for effecting same

DE60116615T2|2006-09-07|13-SUBSTITUTED MILBEMYCIN DERIVATIVES, THEIR PRODUCTION AND THEIR USE AGAINST INSECTS AND OTHER DAMAGES

JP2686311B2|1997-12-08|Antiparasitic avermectin derivative

Bull et al.1967|Comparative fate of the geometric isomers of phosphamidon in plants and animals

BG60271B2|1994-03-31|13-alkyl-23-imino- and 13-halo-23imino derivatives of ll-f28249 and their use as endo- and ecto-parasitcidal, insecticidal, acaricidal and nematocidal agents

US4281016A|1981-07-28|Nematocidal composition

US5643886A|1997-07-01|Avermectins and milbemycins to treat parasitic infestations in dogs

RU2015981C1|1994-07-15|Process for preparing macrocyclic compounds

RU2029770C1|1995-02-27|Process for preparing macrolidic compounds

Reed et al.1983|Investigation of antifeedant and other insecticidal activities of trewiasine towards the striped cucumber beetle and codling moth

JP3762465B2|2006-04-05|13-position ether-substituted milbemycin derivatives having insecticidal activity

WO1995010187A1|1995-04-20|Pesticidal compounds

JP2000500473A|2000-01-18|Fluorobutenoyloxyacetamide

同族专利:

公开号 | 公开日

DK653287D0|1987-12-11|

OA08698A|1989-03-31|

PT86350B|1990-11-07|

PT86350A|1988-01-01|

AT73805T|1992-04-15|

DK168488B1|1994-04-05|

KR960013079B1|1996-09-30|

AU605218B2|1991-01-10|

GR3004882T3|1993-04-28|

IL84801A|1992-02-16|

ZA879279B|1989-08-30|

HUT45982A|1988-09-28|

AR243528A1|1993-08-31|

CN87108339A|1988-07-13|

CN1020114C|1993-03-17|

IL84801D0|1988-06-30|

US5008191A|1991-04-16|

CA1338050C|1996-02-13|

PH26780A|1992-10-13|

AU8247987A|1988-06-23|

NZ222884A|1992-02-25|

RU1836426C|1993-08-23|

DK168994B1|1994-07-25|

DK90393A|1993-08-04|

DE3777604D1|1992-04-23|

DK90393D0|1993-08-04|

EP0274871B1|1992-03-18|

BR8706745A|1988-07-19|

CN1028530C|1995-05-24|

EG18720A|1993-12-30|

ES2033325T3|1993-03-16|

KR880007740A|1988-08-29|

EP0274871A1|1988-07-20|

HU198723B|1989-11-28|

DK653287A|1988-06-12|

CN1064866A|1992-09-30|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US3984564A|1972-06-08|1976-10-05|Sankyo Company Limited|Antibiotic substances B-41, their production and their use as insecticides and acaricides|

US4429042A|1978-09-08|1984-01-31|Merck & Co., Inc.|Strain of Streptomyces for producing antiparasitic compounds|

US4378353A|1981-02-17|1983-03-29|Merck & Co., Inc.|Novel C-076 compounds|

US4412991A|1981-08-28|1983-11-01|Merck & Co., Inc.|22-Hydroxy derivatives of C-076 compounds, pharmaceutical compositions and method of use|

NZ201681A|1981-09-03|1985-11-08|Merck & Co Inc|Avermectin derivatives and parasiticidal compositions|

US4415669A|1981-12-07|1983-11-15|Merck & Co., Inc.|Substance and process for its production|

US4582852A|1983-11-02|1986-04-15|Ciba-Geigy Corporation|14- and 15-hydroxy milbemycin derivatives for controlling plant and animal parasites|

US4547491A|1984-07-18|1985-10-15|Merck & Co., Inc.|C-8A-Oxo-avermectin and milbemycin derivatives, pharmaceutical compositions and method of use|

NZ215917A|1985-05-02|1989-10-27|Merck & Co Inc|22-oh milbemycin derivatives and parasiticidal compositions|

GB8606123D0|1986-03-12|1986-04-16|Glaxo Group Ltd|Chemical compounds|

GB8606116D0|1986-03-12|1986-04-16|Glaxo Group Ltd|Process|

GB8606120D0|1986-03-12|1986-04-16|Glaxo Group Ltd|Process|

JP2587241B2|1986-07-24|1997-03-05|ビ−チヤム・グル−プ・ピ−エルシ−|Novel compound, production method thereof and pharmaceutical composition containing the same|

AR243528A1|1986-12-11|1993-08-31|Sankyo Co|A procedure for preparing macrolide compounds, and a procedure producing a pesticide compound with them.|

EP0277916B1|1987-02-04|1994-05-25|Ciba-Geigy Ag|Microbial process for producing mylbemycin derivatives|

AU615921B2|1987-07-07|1991-10-17|Kumiai Chemical Industry Co., Ltd.|Antibiotic ksb-1939 compounds and production process thereof as well as pesticidal agents containing same|

JP6429378B2|2014-12-15|2018-11-28|日本碍子株式会社|Secondary battery using hydroxide ion conductive ceramic separator|JP2587241B2|1986-07-24|1997-03-05|ビ−チヤム・グル−プ・ピ−エルシ−|Novel compound, production method thereof and pharmaceutical composition containing the same|

AR243528A1|1986-12-11|1993-08-31|Sankyo Co|A procedure for preparing macrolide compounds, and a procedure producing a pesticide compound with them.|

US5212322A|1986-12-11|1993-05-18|Sankyo Company, Limited|Macrolide compounds, their preparation and their use|

AU615921B2|1987-07-07|1991-10-17|Kumiai Chemical Industry Co., Ltd.|Antibiotic ksb-1939 compounds and production process thereof as well as pesticidal agents containing same|

NZ233680A|1989-05-17|1995-02-24|Beecham Group Plc|Avermectins and milbemycins and compositions thereof|

IT1255135B|1992-05-05|1995-10-20|ACTIVE INGREDIENT BASED ON AVERMECTINE, STRAW AND PROCEDURE FOR ITS PREPARATION AND VETERINARY COMPOSITION THAT CONTAINS IT.|

US5364623A|1993-04-30|1994-11-15|Bristol-Myers Squibb Company|Antibiotic produced by Bacillus subtilis ATCC 55422 capable of inhibiting bacteria|

US5362863A|1993-09-29|1994-11-08|Merck & Co., Inc.|Process for the preparation of 4"-amino avermectin compounds|

AU4925100A|1999-05-26|2000-12-18|Novartis Ag|4-substituted milbemycin derivatives|

JP4373080B2|2002-12-24|2009-11-25|三井化学アグロ株式会社|Purification of milbemycins|

EP2886640A1|2013-12-18|2015-06-24|Riga Technical University|Process for isolation of milbemycins A3 and A4|

CN103833811A|2014-03-25|2014-06-04|武汉大学|Abamectin derivative and preparation method thereof|

CN106148216B|2015-03-27|2019-06-04|浙江海正药业股份有限公司|A kind of streptomycete and its method for producing mibemycin A3|

CN106148215B|2015-03-27|2019-06-14|浙江海正药业股份有限公司|A kind of streptomycete and its method for producing mibemycin A4|

CN104860961B|2015-04-10|2017-08-04|新宇药业股份有限公司|One kind prepares 5 oxygen（P-nitrophenyl formyl）The method of nimoctin|

CN109516996B|2018-11-26|2021-12-17|山东农业大学|Macrolide derivative, synthesis and application thereof|

法律状态:
2006-04-10| REG| Reference to a code of a succession state|Ref country code: RU Ref legal event code: PC4A Effective date: 20060209 |

2010-07-20| REG| Reference to a code of a succession state|Ref country code: RU Ref legal event code: MM4A Effective date: 20061211 |

优先权:

申请号 | 申请日 | 专利标题

JP61295452|1986-12-11|

[返回顶部]